CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

OXON’s FREE LIVE ONLINE REAL WORLD MASTERCLASS SERIES 2022-2023

OXON Masterclasses

FREE LIVE REAL WORLD MASTERCLASS SERIES 2022-2023

‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’

Dates: Monthly starting in February 2022 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST

OXON is resuming the series of masterclasses on real world evidence starting in February 2022

This Masterclass series follows the successful Masterclasses in 2021on real-world studies and RCTs by OXON and the eminent statistician, Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (devised: ‘Pocock Stopping Rule’, ‘Win Ratio’. ‘Individualising benefit-risk’); extensive experience with EMA/FDA and data monitoring committees (including adaptive platform Covid-19 DISCOVERY trial); >500 publications (100+ NEJM/Lancets) mainly of trials and epidemiology.

The series provides practical knowledge and advice from national academic experts to apply to field, secondary data and hybrid observational studies for safety, HEOR/market access and clinical development. It is aimed at professionals in the biopharmaceutical and medical device industries, anywhere in the world, involved in the production of real-world evidence and conduct of observational studies in Europe and Asia.

UPCOMING MASTERCLASSES CALENDAR

Convert to my timezone

TitleDateStart TimeDurationRegister
Free Live Masterclass Series on RW Studies. Session 7: Harnessing big biobanks for precision medicine in China OXON’s Free Live Real-World Masterclass Series
"Harnessing big biobanks for precision medicine in China: How to ensure success and avoid pitfalls"

Date: Wednesday, 14 September 2022 at 5pm CEST | 4pm BST | 11am EDT | 8am PST

In 60 minutes, get an overall picture of Chinese healthcare and establishing, managing, and using the largest Chinese Kadoori biobank. Learn how the Chinese biobank can be used for drug target validation, risk prediction, disease prevention and treatment.

Topics include:
• Structure of healthcare and demographics
• How the Kadoori biobank uses the healthcare system in China
• Uses of the Kadoori biobank, with examples
• Strengths and weaknesses for observational studies

CHAIR: Nawab Qizilbash MRCP(UK) MSc DPhil(Oxon)
Senior Clinical Epidemiologist, OXON
Hon. Associate Professor, London School of Hygiene and Tropical Medicine
Clinical Observer, Madrid and Formerly Hon. Consultant Physician, Oxford

KEY SPEAKER: Prof. Zhengming Chen
Richard Peto Chair of Epidemiology, University of Oxford and Honorary Professor of Peking Union Medical College and Fudan University.

Details:
- We will be using GoToWebinar.
- You can join our session by using a Mac, PC or a mobile device.
- You will receive a confirmation email. Use the link to join the session, or login at https://global.gotowebinar.com/join and enter the 9-digit Webinar ID and the email address you used to register.

Please start registering by entering your data.
14 Sep, 202217:00 CEST1 hour
Register

About OXON’s Free Live Masterclass Series on RW Studies

These are masterclass sessions to understand the healthcare for RW studies, led by leading professors of pharmacoepidemiology in Europe and Asia, centred on the practical theme of  “How to ensure success of your RWE studies and avoid pitfalls”

The series will be delivered by leading native pharmacoepidemiologists together with OXON, and it will be centred on understanding healthcare and data sources to fulfil RW field and secondary data studies in their various countries.

The current series will highlight the changes and data sources as a result of the Covid-19 pandemic.

The series will have additional ad-hoc Masterclasses on specific topics, such as:

  • External Control Groups for Regulatory and HTA submissions
  • Hybrid Pregnancy Safety Studies: New Approach
  • Multi-country RW Data Collection Studies
  • Multi-country RW Secondary Data Studies
  • Evaluation of Risk Minimization Measures (with an ex-PRAC member)

We will involve Professor Stuart Pocock’s extensive experience of trials, epidemiology, data monitoring and EMA/FDA for several of these topics.

LEARN MORE

REGISTER TO GET UPDATES